BridgeMD
New treatment option for Spinal Cord Injuries
Official title Assessment of a Robotic Exoskeleton for Upper Limb Rehabilitation
ClinicalTrials.gov ID: NCT05615766
What this study is testing
- What it's testing
- Rehabilitation robotics has the potential to facilitate rehabilitation at home and empower people with spinal injuries to self-manage increasing their independence and improving their quality of life. The objective of this study is to assess for the first time in the NHS the efficacy of a commercial robotic orthosis for upper limb rehabilitation in patients with spinal cord injury.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18+ years.
- The levels of C5 C6 Asia C/D would provide individuals with elbow and hand impairment and potentially functional shoulder movements. C7, C8...
- Some gross shoulder movement at start of the trial to enable changes at the elbow/hand, to have the greatest potential for functional change.
- Preservation of hand sensation as base for motor restoration.
- Some sitting balance would give the best opportunity for the arm to be released for functional upper limb activity.
See the full eligibility criteria
- Age 18+ years.
- The levels of C5 C6 Asia C/D would provide individuals with elbow and hand impairment and potentially functional shoulder movements. C7, C8 individuals could also benefit from the hand component of the device.
- Some gross shoulder movement at start of the trial to enable changes at the elbow/hand, to have the greatest potential for functional change.
- Preservation of hand sensation as base for motor restoration.
- Some sitting balance would give the best opportunity for the arm to be released for functional upper limb activity.
- EMG (muscle activity) evidence of active finger flexion, extension and elbow flexion extension Grade 1-2.
- Minimal or No community functional use of upper limb at start of trial.
- Spasticity MAS 1-3/5.
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
- Oswestry, United Kingdom
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom; Oswestry, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.